CTX-471
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CTX-471, covering 2026-03-23 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies [Phase 1]